Appropriate mammalian expression systems for biopharmaceuticals

Arzneimittel-Forschung/Drug Research

Volumn 48, Issue 8, 1998, Pages 870-880

  Werner, Rolf G ^a   Noé, Wolfgang ^a   Kopp, Kristina ^a   Schlüter, Michael ^a  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

Biopharmaceuticals; Expression systems; Mammalian cell culture; Transgenic animals

Indexed keywords

COLONY STIMULATING FACTOR; GAMMA INTERFERON; GLYCOPROTEIN; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN DERIVATIVE; N ACETYLNEURAMINIC ACID; PLASMINOGEN ACTIVATOR; RECOMBINANT DNA;

ANIMAL CELL; ARTICLE; BIOTECHNOLOGY; CHO CELL; DRUG SAFETY; DRUG SYNTHESIS; FERMENTATION; FIBROBLAST; GENE EXPRESSION SYSTEM; GENETIC STABILITY; GLYCOSYLATION; HUMAN; HUMAN CELL; MAMMAL CELL; NONHUMAN; RECOMBINANT DNA TECHNOLOGY; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; BASE SEQUENCE; BIOLOGICAL PRODUCTS; CELLS, CULTURED; CRICETINAE; GENETIC VECTORS; HUMANS; MAMMALS; MICE; MOLECULAR SEQUENCE DATA; RATS;

EID: 0031853892     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Hofmann, F. K., Anim. Cell Technol., 4th, Annu. Meeting Jpn. Assoc., 135-141 (1991)
2. Fibi, M. R., Kunz, J., Weimer, T. et al., Appl. Biochem. 23, 83 (1996)
3. Lucas, B. K., Giere, L. M., DeMarco, R. A. et al., Nucleic Acids Res. 24, 1774 (1996)
4. Boehringer Ingelheim, WO 920 1055, 23 Jan. 1992, WO 91 - EP 1266, 6 July 1991
5. Boehringer Ingelheim, DE 4021917, 16. Jan 1992, DE 9021917, 10 July 1990
6. Kopp, K., Schlüter, M., Noe, W. et al., Biol. Chem. Hoppe Seyler 374, 950 (1993)
7. Barnett, R. S., Linoli, K. L., Huynh, T. B. et al., J. Am. Chem. Soc. 604, 27 (1995)
8. Kozak, M., Nucleic Acids Research (1987); Am. Chem. Soc. 15, 8125 (1987); WO 93 US 11221, 12 Nov. 1992
9. Kozak, M., Nucleic Acids Research (1987); Am. Chem. Soc. 15, 8125 (1987); WO 93 US 11221, 12 Nov. 1992
10. Kaufman, R. J., Sharp, P. A. J., Am. Chem. Soc. 159, 601 (1982)
11. Reff, M. E., J. Cell, Biochem. Suppl. 18D, 188 (1994)
12. Reff, M. E., Am. Chem. Soc. (1994)
13. Bebbington, C. R., Renner, G., Thomson, S., et al., Bio/Technology 10, 169 (1992)
14. Hassell, T., Brand, H., Renner, G. et al., Anim. Cell Technol. 42, (1992)
15. Brown, M. E., Renner, G., Field, R. P. et al., Cytotechnology 9, 231 (1992)
16. Birch, J. R., Metacalfe, H. K., Froud, S. J., Cytotechnology 14 (Suppl. 1), 1.9 (1994)
17. Behringwerke, DE 402 8800, 12.03. 1992, DE 90 288 00, 11. 09. 1990
18. Lönnerdal, B., Am. J. Clin. Natr. 63, 4 622 (1996)
19. EC Guideline: Use of transgenic animals in the manufacture of biological pharmaceutical products for human use (1993)
20. Grosveld, F., Van Assendelft, G. B., Greaves, D. R. et al., Cell 51, 975 (1987)
21. Wilson, C., Bellen, H. J., Gehring, W. J., Annu. Rev. Cell Biol. 6, 679 (1990)
22. Mutsaers, J. H. G., Kamerling, J. P., Devos, R. et al., Eur. J. Biochem. 156, 651 (1986)
23. Riske, F. J., Cullen, B. R., Chizzonite, R., Lymphokine Res. 10, 213 (1991)
24. Ogonah, O. W., Freedman, R. B., Jenkins, N. et al., Biochem. Soc. Trans 23, 100 (1995)
25. James, D. C., Freeman, R. B. Hoare, M. et al., Bio/ Technology 13, 592 (1995)
26. Ogonah, O. W., Rooney, B., Freedman, R. B. et al., Cytotechnology 14 (1994)
27. Jenkins, N., Castro, P., Menon, S. et al., Cytotechnology 15, 209 (1994)
28. Cotter, T. G., All-Rubeai, M., Trends Biotechnol. 13, 150 (1995)